RECRUITING

Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.

Official Title

Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

Quick Facts

Study Start:2017-05-01
Study Completion:2040-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07184957

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:40 Years to 85 Years
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
  2. * Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.
  1. * Men that are not diagnosed with prostate cancer.
  2. * Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.

Contacts and Locations

Study Contact

Majlinda Tafa
CONTACT
(646) 825-6338
Majlinda.Tafa@nyulangone.org
James Wysock, MD
CONTACT
(646) 825-6366
James.Wysock@nyulangone.org

Principal Investigator

James Wysock, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • James Wysock, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-05-01
Study Completion Date2040-12-31

Study Record Updates

Study Start Date2017-05-01
Study Completion Date2040-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Prostate Cancer